New Delhi: India on Tuesday announced that some of the Covid-19 vaccine candidates may get licensed in the next few weeks.
Making this major announcement, Health Secretary Rajesh Bhushan told reporters here that Serum Institute of India (SII) and Bharat Biotech have already applied for emergency use approval.
Also Read: Covid-19 vaccine roll-out: Health Ministry charts out preparatory activities
"Prime Minister Narendra Modi has interacted with all vaccine manufacturers and scientists. There are six vaccine candidates in the clinical trial stage in India," he said.
Preparatory activities for the rollout of the vaccine were being carried out by the Central government in collaboration with states and UTs.
The announcement comes on the same day when Britain launched its mass Covid vaccination program.
Also Read: Biological E, Ohio State Innovation Foundation ink licensing pact for COVID vaccine technology
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!